Page last updated: 2024-08-24

sertraline and Hallucinations

sertraline has been researched along with Hallucinations in 10 studies

Research

Studies (10)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	4 (40.00)	18.2507
2000's	4 (40.00)	29.6817
2010's	2 (20.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Barton, BA; Deligiannidis, KM; Flint, AJ; Kroll-Desrosiers, AR; Meyers, BS; Mulsant, BH; Rothschild, AJ; Whyte, EM	1
Brissos, S; Gama-Marques, J; Jesus, G	1
Gambini, O; Muffatti, R; Scarone, S	1
Balestrieri, M; Bergonzi, P; Cancelli, I; Marcon, G; Zamarian, L	1
Degner, D; Grohmann, R; Kropp, S; Porzig, J; Rüther, E	1
Kaminski, CA; Robbins, MS; Weibley, RE	1
Dike, GL	1
Dryden-Edwards, RC; Reiss, AL	1
Bourgeois, JA; Johansen, T; Thomas, D; Walker, DM	1
Flockhart, DA; Rosebraugh, CJ; Woosley, RL; Yasuda, SU	1

Trials

1 trial(s) available for sertraline and Hallucinations

Article	Year
A gender analysis of the study of pharmacotherapy of psychotic depression (STOP-PD): gender and age as predictors of response and treatment-associated changes in body mass index and metabolic measures. The Journal of clinical psychiatry, 2013, Volume: 74, Issue:10 Topics: Adult; Age Factors; Aged; Antipsychotic Agents; Benzodiazepines; Body Mass Index; Body Weight; Depressive Disorder, Major; Diagnostic and Statistical Manual of Mental Disorders; Double-Blind Method; Drug Monitoring; Drug Therapy, Combination; Female; Hallucinations; Humans; Male; Metabolism; Middle Aged; Olanzapine; Outcome Assessment, Health Care; Psychiatric Status Rating Scales; Sertraline; Sex Factors; Socioeconomic Factors; Treatment Outcome	2013

Article

Year

A gender analysis of the study of pharmacotherapy of psychotic depression (STOP-PD): gender and age as predictors of response and treatment-associated changes in body mass index and metabolic measures.

The Journal of clinical psychiatry, 2013, Volume: 74, Issue:10

Topics: Adult; Age Factors; Aged; Antipsychotic Agents; Benzodiazepines; Body Mass Index; Body Weight; Depressive Disorder, Major; Diagnostic and Statistical Manual of Mental Disorders; Double-Blind Method; Drug Monitoring; Drug Therapy, Combination; Female; Hallucinations; Humans; Male; Metabolism; Middle Aged; Olanzapine; Outcome Assessment, Health Care; Psychiatric Status Rating Scales; Sertraline; Sex Factors; Socioeconomic Factors; Treatment Outcome

2013

Other Studies

9 other study(ies) available for sertraline and Hallucinations

Article	Year
[Olfactory reference syndrome and hyperhidrosis: comorbidity in one patient]. Revista de neurologia, 2014, Dec-16, Volume: 59, Issue:12 Topics: Adult; Body Dysmorphic Disorders; Clomipramine; Cognitive Behavioral Therapy; Combined Modality Therapy; Comorbidity; Drug Substitution; Halitosis; Hallucinations; Humans; Hyperhidrosis; Male; Models, Psychological; Obsessive-Compulsive Disorder; Psychotropic Drugs; Sertraline; Syndrome	2014
An olfactory reference syndrome successfully treated by aripiprazole augmentation of antidepressant therapy. Cognitive and behavioral neurology : official journal of the Society for Behavioral and Cognitive Neurology, 2008, Volume: 21, Issue:4 Topics: Aged; Antidepressive Agents; Antipsychotic Agents; Aripiprazole; Delusions; Electroencephalography; Female; Hallucinations; Humans; Magnetic Resonance Imaging; Neuropsychological Tests; Olfactory Bulb; Piperazines; Psychiatric Status Rating Scales; Quinolones; Sertraline; Smell	2008
Visual hallucinations with sertraline. The Journal of clinical psychiatry, 2004, Volume: 65, Issue:3 Topics: Aged; Antidepressive Agents; Depressive Disorder, Major; Female; Hallucinations; Humans; Sertraline	2004
Pseudohallucinations associated with moclobemide: a case report. Pharmacopsychiatry, 2005, Volume: 38, Issue:4 Topics: Adult; Antidepressive Agents; Depressive Disorder; Hallucinations; Humans; Male; Mianserin; Mirtazapine; Moclobemide; Monoamine Oxidase Inhibitors; Sertraline	2005
Sertraline intoxication in a child. Annals of emergency medicine, 1994, Volume: 23, Issue:6 Topics: 1-Naphthylamine; Antidepressive Agents; Child; Coma; Fever; Flushing; Hallucinations; Humans; Hypertension; Male; Poisoning; Sertraline; Tachycardia; Tremor	1994
Triphasic waves in serotonin syndrome. Journal of neurology, neurosurgery, and psychiatry, 1997, Volume: 62, Issue:2 Topics: 1-Naphthylamine; Aged; Amantadine; Antiparkinson Agents; Brain Diseases; Carbidopa; Drug Combinations; Drug Therapy, Combination; Electroencephalography; Hallucinations; Humans; Levodopa; Male; Myoclonus; Parkinson Disease; Selective Serotonin Reuptake Inhibitors; Sertraline; Syndrome	1997
Differential response of psychotic and obsessive symptoms to risperidone in an adolescent. Journal of child and adolescent psychopharmacology, 1996,Summer, Volume: 6, Issue:2 Topics: 1-Naphthylamine; Adolescent; Antidepressive Agents; Antipsychotic Agents; Clomipramine; Hallucinations; Haloperidol; Humans; Male; Obsessive-Compulsive Disorder; Psychotic Disorders; Risperidone; Sertraline; Trifluoperazine	1996
Visual hallucinations associated with fluoxetine and sertraline. Journal of clinical psychopharmacology, 1998, Volume: 18, Issue:6 Topics: Adult; Antidepressive Agents; Depression; Fluoxetine; Hallucinations; Humans; Male; Sertraline	1998
Visual hallucination and tremor induced by sertraline and oxycodone in a bone marrow transplant patient. Journal of clinical pharmacology, 2001, Volume: 41, Issue:2 Topics: Adult; Antidepressive Agents; Antitussive Agents; Bone Marrow Transplantation; Hallucinations; Humans; Male; Oxycodone; Sertraline; Tremor	2001